» Articles » PMID: 37150843

Clustering Psychopathology in Male Anabolic-androgenic Steroid Users and Nonusing Weightlifters

Overview
Journal Brain Behav
Specialty Psychology
Date 2023 May 7
PMID 37150843
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Prior research has demonstrated that personality disorders and clinical psychiatric syndromes are common among users of anabolic-androgenic steroids (AAS). However, the prevalence, expression, and severity of psychopathology differ among AAS users and remain poorly understood. In this study, we examine the existence of potential clinically coherent psychopathology subgroups, using cluster procedures.

Methods: A sample of 118 male AAS users and 97 weightlifting nonusers was assessed using the Millon Clinical Multiaxial Inventory-III (MCMI-III), measuring personality disorders and clinical syndromes. Group differences in MCMI-III scales were assessed using Wilcoxon-Mann-Whitney tests and Fisher's exact test. Agglomerative hierarchical clustering was used to identify clusters based on MCMI-III scale scores from the whole sample.

Results: AAS users displayed significantly higher scores on all personality disorder (except narcissistic) and clinical syndrome scales compared to nonusing weightlifters. The clustering analysis found four separate clusters with different levels and patterns of psychopathology. The "no psychopathology" cluster was most common among nonusing weightlifters, while the three other clusters were more common among AAS users: "severe multipathology," "low multipathology," and "mild externalizing." The "severe multipathology" cluster was found almost exclusively among AAS users. AAS users also displayed the highest scores on drug and alcohol dependence syndromes.

Conclusions: AAS users in our sample demonstrated greater psychopathology than the nonusing weightlifters, with many exhibiting multipathology. This may pose a significant challenge to clinical care for AAS users, particularly as there appears to be significant variation in psychopathology in this population. Individual psychiatric profiles should be taken into consideration when providing treatment to this group.

Significant Outcomes: As a group, AAS users displayed markedly greater psychopathology than nonusing weightlifters. Multipathology was common among AAS users. Four different subgroups of personality profiles were identified with distinct patterns of pathology and severity.

Limitations: The cross-sectional nature of the study precludes inferences about causality. The study is limited by possible selection bias, as participants choosing to be involved in research may not be entirely representative for the group as a whole. The study is vulnerable to information bias, as the results are based on self-report measures and interviews.

Citing Articles

Relationship Between Anabolic-Androgenic Steroid Use, Aggression, and Narcissism in Male Bodybuilders.

Ceto E, Yigitoglu P, Yavuz H Medicina (Kaunas). 2025; 61(2).

PMID: 40005358 PMC: 11857202. DOI: 10.3390/medicina61020241.


Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) - A pilot study protocol.

Havnes I, Henriksen H, Johansen P, Bjornebekk A, Neupane S, Hisdal J MethodsX. 2024; 13:102810.

PMID: 39022178 PMC: 11253696. DOI: 10.1016/j.mex.2024.102810.


Supraphysiological testosterone levels from anabolic steroid use and reduced sensitivity to negative facial expressions in men.

Scarth M, Hauger L, Thorsby P, Leknes S, Hullstein I, Westlye L Psychopharmacology (Berl). 2023; 241(4):701-715.

PMID: 37993638 PMC: 10927904. DOI: 10.1007/s00213-023-06497-2.


Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters.

Jorstad M, Scarth M, Torgersen S, Pope H, Bjornebekk A Brain Behav. 2023; 13(7):e3040.

PMID: 37150843 PMC: 10338822. DOI: 10.1002/brb3.3040.

References
1.
Murray S, Griffiths S, Mond J, Kean J, Blashill A . Anabolic steroid use and body image psychopathology in men: Delineating between appearance- versus performance-driven motivations. Drug Alcohol Depend. 2016; 165:198-202. DOI: 10.1016/j.drugalcdep.2016.06.008. View

2.
Caspi A, Houts R, Belsky D, Goldman-Mellor S, Harrington H, Israel S . The p Factor: One General Psychopathology Factor in the Structure of Psychiatric Disorders?. Clin Psychol Sci. 2014; 2(2):119-137. PMC: 4209412. DOI: 10.1177/2167702613497473. View

3.
Lindqvist A, Moberg T, Eriksson B, Ehrnborg C, Rosen T, Fahlke C . A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health. Br J Sports Med. 2013; 47(15):965-9. DOI: 10.1136/bjsports-2012-091340. View

4.
Pope Jr H, Kanayama G, Hudson J . Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2011; 71(3):254-61. PMC: 3218214. DOI: 10.1016/j.biopsych.2011.06.024. View

5.
Jorstad M, Scarth M, Torgersen S, Pope H, Bjornebekk A . Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters. Brain Behav. 2023; 13(7):e3040. PMC: 10338822. DOI: 10.1002/brb3.3040. View